Annual EBITDA
-$396.56M$4.65M+1.16%
Summary
- Current Value
- As of today, GH annual EBITDA is -$396.56M, up +1.16% on
- Historical Performance
- GH annual EBITDA is up +20.51% over the past 3 years, down -73.03% over the past 5 years
- All-Time High Comparison
- GH annual EBITDA is currently -887.60% below its historical high of -$40.15M set on
- 3-Year Low Comparison
- GH annual EBITDA is +23.68% above its 3-year low of -$519.63M reached on
- Sector Comparison
- GH annual EBITDA is higher than 2.38% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$396.56M | +1.2% | +20.5% | -73.0% | -887.6% | |
| Quarterly EBITDA | -$119.56M | -24.0% | -10.2% | -29.9% | – | |
| TTM EBITDA | -$431.28M | -2.8% | +13.6% | -22.8% | – | |
| Price | $159.54 | +172.4% | +348.3% | +57.5% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $982.02M | +32.9% | +118.5% | +242.5% | +3789.3% | |
| Annual EPS | -$3.32 | +6.6% | +48.2% | -27.6% | -514.8% | |
| -$436.30M | +1.6% | +18.4% | -77.9% | -895.0% | ||
| Annual Net Income | -$416.28M | +4.6% | +36.4% | -69.0% | -802.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$396.56M | at high | |
| 5Y | -$229.19M | N/A | -73.0% |
| All | -$40.15M | -887.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$519.63M | +23.7% | |
| 5Y | -$519.63M | +23.7% | |
| All | -$519.63M | +23.7% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$396.56M | +1.2% | |
| -$401.21M | +22.8% | |
| -$519.63M | -4.2% | |
| -$498.91M | -29.1% | |
| -$386.35M | -68.6% |
| Year | Value | Change |
|---|---|---|
| -$229.19M | -235.4% | |
| -$68.34M | +20.4% | |
| -$85.81M | -20.2% | |
| -$71.41M | -77.8% | |
| -$40.15M | - |
FAQ
- What is the current annual EBITDA of GH?
- As of today, GH annual EBITDA is -$396.56M
- What is 1-year change in GH annual EBITDA?
- GH annual EBITDA is up +1.16% year-over-year
- What is 3-year change in GH annual EBITDA?
- GH annual EBITDA is up +20.51% over the past 3 years
- How far is GH annual EBITDA from its all-time high?
- GH annual EBITDA is currently -887.60% below its historical high of -$40.15M set on December 31, 2016
- How does GH annual EBITDA rank versus sector peers?
- GH annual EBITDA is higher than 2.38% of companies in Healthcare sector
- When is GH next annual earnings release?
- As of today, the next annual earnings release for GH has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$119.56M$7.65M-6.84%
Summary
- Current Value
- As of today, GH quarterly EBITDA is -$119.56M, down -6.84% on
- Historical Performance
- GH quarterly EBITDA is down -24.01% year-over-year, down -10.21% over the past 3 years
- All-Time High Comparison
- GH quarterly EBITDA is currently -886.61% below its historical high of -$12.12M set on
- 3-Year Low Comparison
- GH quarterly EBITDA is +35.83% above its 3-year low of -$186.31M reached on
- Sector Comparison
- GH quarterly EBITDA is higher than 1.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$119.56M | -6.8% | -24.0% | -10.2% | -29.9% | |
| Annual EBITDA | -$396.56M | – | +1.2% | +20.5% | -73.0% | |
| TTM EBITDA | -$431.28M | -5.7% | -2.8% | +13.6% | -22.8% | |
| Price | $159.54 | +62.0% | +172.4% | +348.3% | +57.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $334.98M | +11.0% | +44.3% | +144.2% | +263.7% | |
| Quarterly EPS | -$0.90 | -5.9% | -12.3% | -35.2% | +6.2% | |
| -$129.12M | -6.4% | -21.3% | -8.4% | -32.2% | ||
| Quarterly Net Income | -$120.14M | -7.2% | -20.3% | -65.1% | -23.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$89.59M | -33.5% | |
| 3Y | -$88.97M | -34.4% | |
| 5Y | -$88.97M | -34.4% | |
| All | -$12.12M | -886.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$119.56M | at low | |
| 3Y | -$186.31M | +35.8% | |
| 5Y | -$186.31M | +35.8% | |
| All | -$186.31M | +35.8% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of GH?
- As of today, GH quarterly EBITDA is -$119.56M
- What is GH quarterly EBITDA most recent change?
- GH quarterly EBITDA was down -6.84% on June 30, 2026
- What is 1-year change in GH quarterly EBITDA?
- GH quarterly EBITDA is down -24.01% year-over-year
- How far is GH quarterly EBITDA from its all-time high?
- GH quarterly EBITDA is currently -886.61% below its historical high of -$12.12M set on March 31, 2018
- How does GH quarterly EBITDA rank versus sector peers?
- GH quarterly EBITDA is higher than 1.82% of companies in Healthcare sector
- When is GH next earnings release?
- The next earnings release for GH is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$431.28M$23.14M-5.67%
Summary
- Current Value
- As of today, GH TTM EBITDA is -$431.28M, down -5.67% on
- Historical Performance
- GH TTM EBITDA is down -2.82% year-over-year, up +13.61% over the past 3 years
- All-Time High Comparison
- GH TTM EBITDA is currently -1500.41% below its historical high of -$26.95M set on
- 3-Year Low Comparison
- GH TTM EBITDA is +17.05% above its 3-year low of -$519.91M reached on
- Sector Comparison
- GH TTM EBITDA is higher than 2.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$431.28M | -5.7% | -2.8% | +13.6% | -22.8% | |
| Annual EBITDA | -$396.56M | – | +1.2% | +20.5% | -73.0% | |
| Quarterly EBITDA | -$119.56M | -6.8% | -24.0% | -10.2% | -29.9% | |
| Price | $159.54 | +62.0% | +172.4% | +348.3% | +57.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.18B | +9.5% | +42.7% | +131.9% | +265.6% | |
| TTM EPS | -$3.50 | -2.9% | -4.6% | +28.8% | +7.1% | |
| -$469.73M | -5.1% | -1.9% | +13.1% | -26.6% | ||
| TTM Net Income | -$453.44M | -4.7% | -9.6% | +10.8% | -22.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$397.03M | -8.6% | |
| 3Y | -$397.03M | -8.6% | |
| 5Y | -$351.36M | N/A | -22.8% |
| All | -$26.95M | -1500.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$431.28M | at low | |
| 3Y | -$519.91M | +17.1% | |
| 5Y | -$519.91M | +17.1% | |
| All | -$519.91M | +17.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of GH?
- As of today, GH TTM EBITDA is -$431.28M
- What is GH TTM EBITDA most recent change?
- GH TTM EBITDA was down -5.67% on June 30, 2026
- What is 1-year change in GH TTM EBITDA?
- GH TTM EBITDA is down -2.82% year-over-year
- How far is GH TTM EBITDA from its all-time high?
- GH TTM EBITDA is currently -1500.41% below its historical high of -$26.95M set on September 30, 2017
- How does GH TTM EBITDA rank versus sector peers?
- GH TTM EBITDA is higher than 2.20% of companies in Healthcare sector
- When is GH next earnings release?
- The next earnings release for GH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628026000013/0001576280-26-000013-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh